Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Bruce Mitlak"'
Autor:
Ruban Dhaliwal, Didier Hans, Gary Hattersley, Bruce Mitlak, Lorraine A Fitzpatrick, Yamei Wang, Ann V Schwartz, Paul D Miller, Robert G Josse
Publikováno v:
JBMR Plus, Vol 5, Iss 2, Pp n/a-n/a (2021)
Externí odkaz:
https://doaj.org/article/e6eed3f93220457fbc078aa37679c19d
Autor:
Heike Arlt, Tara Mullarkey, Dorothy Hu, Roland Baron, Michael S. Ominsky, Bruce Mitlak, Beate Lanske, Tatiana Besschetnova
Publikováno v:
Bone Reports, Vol 13, Iss , Pp 100291- (2020)
Intermittent administration of PTH type 1 receptor (PTH1R) agonists increases bone remodeling, with greater stimulation of bone formation relative to bone resorption causing net gains in bone mass. This pharmacodynamic feature underlies the bone-buil
Externí odkaz:
https://doaj.org/article/f77974bf4fd94ac981d1a13b3f54cd1a
Autor:
Ruban Dhaliwal, Didier Hans, Gary Hattersley, Bruce Mitlak, Lorraine A Fitzpatrick, Yamei Wang, Ann V Schwartz, Paul D Miller, Robert G Josse
Publikováno v:
JBMR Plus, Vol 4, Iss 4, Pp n/a-n/a (2020)
ABSTRACT Type 2 diabetes mellitus (T2DM) increases fracture risk despite normal or increased BMD. Abaloparatide reduces fracture risk in patients with postmenopausal osteoporosis (PMO); however, its efficacy in women with T2DM is unknown. This post h
Externí odkaz:
https://doaj.org/article/fe38865d972b4df78653cb2dd78b4f71
Autor:
Tadatoshi Sato, Christian D. Castro Andrade, Sung-Hee Yoon, Yingshe Zhao, William J. Greenlee, Patricia C. Weber, Usha Viswanathan, John Kulp, Daniel J. Brooks, Marie B. Demay, Mary L. Bouxsein, Bruce Mitlak, Beate Lanske, Marc N. Wein
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America. 119(50)
Osteoporosis is a major public health problem. Currently, there are no orally available therapies that increase bone formation. Intermittent parathyroid hormone (PTH) stimulates bone formation through a signal transduction pathway that involves inhib
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c6fb817191c9c4d82d8a4ca4bdafcdb9
https://pubmed.ncbi.nlm.nih.gov/36472957
https://pubmed.ncbi.nlm.nih.gov/36472957
Autor:
null Edward Czerwinski, null Jose Cardona, null Rafal Plebanski, null Chris Recknor, null Tamara Vokes, null Kenneth G. Saag, null Neil Binkley, null E. Michael Lewiecki, null Jonathan Adachi, null Dorota Knychas, null David Kendler, null Eric Orwoll, null Yinzhong Chen, null Leny Pearman, null Y. Heather Li, null Bruce Mitlak
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8c24c9f5a40de4499c4d6f86a643b8dd
https://doi.org/10.1002/jbmr.4719/v2/response1
https://doi.org/10.1002/jbmr.4719/v2/response1
Autor:
Edward Czerwinski, Jose Cardona, Rafal Plebanski, Chris Recknor, Tamara Vokes, Kenneth G Saag, Neil Binkley, E Michael Lewiecki, Jonathan Adachi, Dorota Knychas, David Kendler, Eric Orwoll, Yinzhong Chen, Leny Pearman, Y Heather Li, Bruce Mitlak
Publikováno v:
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral ResearchReferences. 37(12)
Abaloparatide significantly increased bone mineral density (BMD) in women with postmenopausal osteoporosis and decreased risk of vertebral, nonvertebral, and clinical fractures compared with placebo. The Abaloparatide for the Treatment of Men with Os
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::17070371ee42bf7cc267ca1661f59f2b
https://pubmed.ncbi.nlm.nih.gov/36190391
https://pubmed.ncbi.nlm.nih.gov/36190391
Mini abstract: Real-world evidence on the comparative effectiveness and safety of abaloparatide versus teriparatide in women with osteoporosis may help inform treatment decisions. Following 18 months of treatment, abaloparatide was comparable to teri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::605c7b2573ace780a52972369b55be37
https://eprints.soton.ac.uk/457512/
https://eprints.soton.ac.uk/457512/
Autor:
null Richard Eastell, null Dennis M. Black, null Li‐Yung Lui, null Arkadi Chines, null Fernando Marin, null Sundeep Khosla, null Anne E. de Papp, null Jane A. Cauley, null Bruce Mitlak, null Charles E. McCulloch, null Eric Vittinghoff, null Douglas C. Bauer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::58ece064043eb3a0d8096c20ff737800
https://doi.org/10.1002/jbmr.4178/v3/response1
https://doi.org/10.1002/jbmr.4178/v3/response1
Autor:
Jörg, Goldhahn, Bruce, Mitlak, Per, Aspenberg, John A, Kanis, René, Rizzoli, Jean-Yves, Reginster, Michael, Wagener
Publikováno v:
Journal of Bone and Joint Surgery. American Volume, Vol. 90 Suppl 1 (2008) pp. 43-47
Osteoporosis increases fracture risk, especially in metaphyseal bone. Fractures seriously impair function and quality of life and incur large direct and indirect costs. Although the prevention of fractures is certainly the option, a fast and uneventf
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a0262f43ec980f10fc54d23867d36781
https://pubmed.ncbi.nlm.nih.gov/18292356
https://pubmed.ncbi.nlm.nih.gov/18292356